Premium
Cutaneous leukocytoclastic vasculitis associated with anti‐tuberculosis drugs
Author(s) -
Avcu Gülhadiye,
Sensoy Gülnar,
Çeliksoy Mehmet Halil,
Sogut Ayhan,
Kefeli Mehmet,
Karli Arzu,
Belet Nursen
Publication year - 2015
Publication title -
pediatrics international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.49
H-Index - 63
eISSN - 1442-200X
pISSN - 1328-8067
DOI - 10.1111/ped.12403
Subject(s) - medicine , leukocytoclastic vasculitis , ethambutol , tuberculosis , dermatology , etiology , rifampicin , malignancy , vasculitis , palpable purpura , granulomatous inflammation , pathology , disease , henoch schonlein purpura
Leukocytoclastic vasculitis ( LCV ), a disease characterized by inflammation of the small vessels, presents with palpable purpura, especially in the lower extremities. Its etiology is known to include drugs, infection, collagen tissue disease, and malignancy, but LCV caused by anti‐tuberculosis drugs is very rarely seen. This report describes the case of a 12‐year‐old girl who developed LCV with rifampicin and ethambutol while undergoing anti‐tuberculosis treatment due to extensive pulmonary involvement.